A carregar...
Systemic anti-CD20 (rituximab) as primary treatment for symptomatic primary uveal lymphoma
PURPOSE: Uveal lymphomas are indolent, frequently choroid-involving neoplasms that are mainly CD20-positive B-cell extranodal marginal zone lymphoma. Irreversible visual loss may occur from retinal detachment and/or glaucoma among untreated symptomatic patients, or from radiation-induced changes sec...
Na minha lista:
| Publicado no: | Am J Ophthalmol Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586989/ https://ncbi.nlm.nih.gov/pubmed/31249903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2019.100484 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|